Connect with us

Press Release

Kelsang Dorjee Aukatsang was shortlisted as Sikyong’s final candidate, causing huge controversy

Published

5 years ago

on

On March 21, the Tibet Exile Organization Committee formally announced the candidates for Sikyong, and the candidates will be formally voted for on April 11. Although the exile organization has not yet been officially recognized by any international organization, the election is still receiving media attention. The main reason was that many internal problems broke out in this election, such as corruption and factional struggles.

Sikyong is the head of the Tibetan exile organization. It is reported that the title was created in 2012. On April 26, 2017, Kashag’s internal circular announced that it would be translated as sikyong in English and became the leader of the Tibetan exile organization. The second and final round of elections will be held on April 11.

Kelsang Dorjee Aukatsang ballots suspected of fraud caused huge controversy

During the election, a huge dispute broke out within the exile organization and many refugee sites regarding the nomination of candidates. However, the frequent scandals during the election made this exile organization even more embarrassing, and the campaign in the epidemic became full of farce and injustice. The biggest controversy is that one of the candidates, Kelsang Dorjee Aukatsang, broke the ballot fraud during the election. According to local reports from the Campa people, Tibetans in exile conducted a public vote during the day. On the day of the vote, Dolma Gyari had a significant lead and had won. However, Kelsang Dorjee Aukatsang quickly caught up with the votes overnight, until February 8 when the ballot results were publicized and completely overtaken. The public results showed that Penpa Tsering won the first place with 24,488 votes, and Kelsang Dorjee Aukatsang won. 14,544 votes. The former Minister of the Interior Dolma Gyari, who was already a big lead, was surpassed by 13,363 votes and lost the final qualification. This is also one of the biggest controversies. If the election cannot be kept fair, the election will be completely meaningless. Regarding the election of Sikyong, the issue of vote-falsification became confusing, and internal voices broke out huge opposition to Kelsang Dorjee Aukatsang’s continued participation in the final election.

Like father, like son.

According to the public, Kelsang Dorjee Aukatsang is the son of Jampa Kalden Aukatsang, the former director of the Security Bureau of the Tibet Exile Organization. The family’s worship of power seems to have not changed. Throughout the campaign, Kelsang Dorjee has been using his father’s story and biography, like His father is running for election. Kelsang Dorjee is 52 years old, but he has been shaping the image of young idols during the campaign. Electors who are more prominent than him have never shown the contribution of his own family to the government in exile and refugees. On the contrary, Kelsang Dorjee Aukatsang has repeatedly used his father’s deeds to increase his influence. This move has aroused dissatisfaction among many voters.

In addition, the excessive political ambitions and desire for power swelled to the extent that they did not respect the Dalai Lama, which has something in common with his father’s image. Kelsang Dorjee Aukatsang is more inclined towards Lobsang Sangay, who has more power, and this seems to be more helpful to his campaign. Kelsang Dorjee Aukatsang deleted the photo of the Dalai Lama in the important public sector Kashag after taking office in order to profit from the campaign, and replaced it with the photo of Lobsang Sangay, which once caused the exile organization and refugees huge dispute.

Indelible corruption

Power is always accompanied by corruption. It is these corrupt leaders who regard Tibetans in exile as tools for seeking money and political benefits for themselves. These actions have also caused dissatisfaction among Tibetans in exile, and even Kelsang Dorjee Aukatsang’s Wikipedia introduction In, first talked about his corruption problem. Tibetans in exile may be more angry about how such a tainted person got so many votes. The number of Tibetans in the exile organization was originally very small, and even launched a joint investigation signed by more than 8,000 people in Kelsang Dorjee Aukatsang, requesting an investigation into the truth of the corruption. In 2015, Kelsang Dorjee Aukatsang assisted Lobsang Sangay in embezzling US$1.5 million from the Tibet Foundation. The money was allegedly used to purchase unnecessary buildings. The method of transfer also caused great suspicion. It was recorded as a “loan receivable” from the account of the Tibet Foundation, but it was not recorded in the account of the Tibet Community Development Foundation, which should have received the funds. In other words, the funds they usually use for health and education projects are used to purchase property. The successor of Aukatsang, Penpa Tsering, discovered the changes in the transaction and the attempt and disclosed the information. As a result, he was immediately dismissed on the grounds of “lack of trust, poor performance and increasing disobedience”. The incident also made Kelsang Dorjee Aukatsang famous for corruption.

Greater power will only lead to greater corruption. The huge controversy among Tibetans in exile in this election is also because the Tibetans in exile have seen this fact clearly, and they hope to choose one that can contribute to their community and development. Instead of finding someone like Kelsang Dorjee Aukatsang who unintentionally fights for the welfare and future of Tibetans in exile, all he does is lies, manipulates, abuses his power, embezzles funds and wastes donations from Tibetans in exile.

Half a century after Tibetans went into exile, most Tibetans in exile are still struggling in settlements of exiles. The leadership of Tibetans in exile must still rely on charity, and more Tibetans in exile hope to find leaders who can lead them to plan for the future. This is not to find a protector of the Dalai Lama or an egoist who uses power for personal gain. Coincidentally, Kelsang Dorjee Aukatsang and Lobsang Sangay recently confessed to using public funds to conduct campaigns during the exchange with Robert Destro, the special coordinator for Tibet. Their so-called political propaganda is actually recommending Kelsang Dorjee Aukatsang to young Tibetans. Such elections are disgusting and frustrating. After he was the director of the American Office of the Tibetan Exile Organization, nothing about Tibetans in exile and their settlements has changed. They are more empty political slogans, without substantive content or meaning.

If Dorjee Aukatsang wins the election in April, Tibetans in exile will face a greater disaster, not a natural disaster but a man-made one. Under the struggle for power, the real problems will be covered up and ignored, and they will be used and deceived by their leaders. Unrequited, submissive refugee status to take advantage of donations from unsuspecting donors; forced to survive on poor grants and donations

We hope that more Tibetans can see the call, sign a joint investigation of Dorjee Aukatsang, recover the donated funds, and seek the living conditions and welfare of Tibetans in exile.

About Author

Alex Jacob

Alex Jacob is a literature author. He was born in Chicago. Alex passion is writing news articles. He writes number of articles and published it.

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

CMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions

Published

1 hour ago

on

June 8, 2026

By

SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that the preclinical results of its self-developed innovative INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”), have been presented in a poster at the American Diabetes Association (ADA) 86th Scientific Sessions (June 5-8, 2026, New Orleans, USA). As the world’s largest and most authoritative annual scientific meeting in the fields of diabetes and metabolic diseases, it convened over 12,000 leading clinicians, researchers, and healthcare professionals worldwide to explore cutting-edge advances in diagnostics, therapies, and technologies.

 

About CMS-D008

CMS-D008 is a self-developed novel siRNA therapy administered by subcutaneous injection. It targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of INHBE-encoded Activin E protein, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. It demonstrates the potential for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. Currently, the Phase I clinical trial of CMS-D008 in healthy subjects is progressing steadily. In the future, it may be developed for the treatment of abdominal obesity and related metabolic diseases.

 

CMS-D008 has demonstrated encouraging preclinical data. The preclinical research results of CMS-D008 presented at the ADA Scientific Sessions showed that in obese animal models, CMS-D008 efficiently and sustainably suppressed INHBE expression, achieving significant weight loss and fat reduction while sparing muscle mass, with a favorable safety profile, indicating the potential for healthy weight loss. Details are as follows:

Title: CMS-D008 specifically silences INHBE mRNA, delivering fat-selective weight loss in preclinical study

Presentation Number: 3079-LB

Presentation format: Poster

Date/Time: June 7, 2026 01:30 PM – 02:30 PM (Local Time)

Location: Hall D-E

Results:

  1. In a high-fat diet-induced model of humanized INHBE obese mouse (hINHBE DIO mouse), CMS-D008 significantly reduced hepatic INHBE mRNA expression and serum Activin E protein levels, leading to marked decreases in body weight, total body fat, and regional fat mass while preserving lean mass.
  2. In a model of obese cynomolgus macaque, CMS-D008 also significantly reduced hepatic INHBE mRNA expression and plasma Activin E protein levels, and effectively suppressed weight gain induced by a sustained high-fat diet.

 

The inclusion of these findings at the ADA Scientific Sessions reflects the international academic community’s interest in the scientific value and clinical potential of CMS-D008 in

3the field of obesity/metabolic treatment. CMS-D008 will synergize with CMS-D005, a self-developed, clinical-stage innovative drug (a GLP-1R/GCGR dual agonist), to deliver highly effective weight-loss benefits and long-term maintenance of results, providing patients with a more comprehensive and innovative treatment option.

 

CMS is committed to in-house R&D as a core driver of its long-term growth and continues to advance innovation in cutting-edge therapeutic areas. Currently, 6 self-developed products with global rights, including CMS-D008, have entered the clinical stage, with over 20 additional self-developed projects steadily progressing in preclinical research. Looking ahead, the Group will continue to focus on unmet medical needs, efficiently advance product R&D and commercialization, and bring more comprehensive and innovative therapies to benefit broad patient population.

 

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

 

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

 

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

 

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

TON Corporation to Launch ‘TonTV’, a Telegram-Native Short-Drama Platform, Globally in September 2026

Published

1 hour ago

on

June 8, 2026

By

A binge-watchable library of two-minute vertical dramas — free, no app-store install, opened from a single Telegram account for the platform’s ~1 billion monthly users.

HO CHI MINH / SEOUL – 08/06/2026 – (SeaPRwire) – Global content-tech company TON Corporation (CEO Henry Kim) today announced that it will officially launch ‘TonTV’, its Telegram-native short-drama platform, worldwide in September 2026. TonTV lets the ~1 billion people who use Telegram each month instantly and freely watch short dramas with a single Telegram account — with no separate app install and no complicated sign-up.

Short drama is one of entertainment’s fastest-rising categories

Short-form drama has moved to the center of global media consumption. Global in-app revenue for short dramas reached $2.98 billion in 2025, up 115% year over year, and in Q4 2025 short-form titles overtook long-form streaming apps in downloads for the first time (733M vs. 658M), according to Sensor Tower and Omdia. With short runtimes, high completion rates, and mobile-first immersion, the format is growing fastest among younger viewers. TonTV places dramas of around two minutes at the heart of this trend — short but intense chapters that build a “can’t-stop-once-you-start” experience.

The Telegram Mini App: tearing down the barrier to entry

TonTV’s core strength is that it runs atop Telegram, a massive global platform. Existing OTT services require a long entry sequence — app-store search → download → install → sign-up → enter payment details. TonTV removes it: open the Mini App inside Telegram → watch instantly, for free.

The user reach that global OTT leaders such as Netflix and Disney+ built over years and at enormous cost is something TonTV can address from day one, across Telegram’s ~1 billion monthly users. This dramatically lowers user-acquisition cost while driving early growth through natural word-of-mouth across Telegram’s groups and channels.

Three years of preparation, and “why we can win”

TonTV did not appear overnight. Over the past three years, TON Corporation has focused on platform-technology development, global content partnerships, and a local-operations model in preparation for launch.

CTO Tony cited the following reasons TonTV can be a market “game changer” rather than a late follower:

• Frictionless reach — among the first specialized short-drama platforms to reach Telegram’s ~1 billion monthly users, free, in one click

• Free entry — anyone can start at no cost, a strong advantage for early user acquisition

• Network effects — discussion, sharing, and recommendation happen at the same moment as viewing

• Viewer-participation rewards — enjoying content itself returns benefits and rewards, building loyalty

• Simultaneous global release — worldwide at once, with no region-by-region app-store approval

On these strengths, TonTV aims to grow beyond short drama into real-time formats such as live streaming over time.

A ‘new stage’ for producers, actors, and staff worldwide

TonTV goes beyond a viewing platform to open opportunity for the global content industry. Producers can showcase work directly to a global audience; actors and staff can widen their stage across borders. For emerging teams and new actors who have struggled to get a chance at traditional broadcasters or large OTTs, TonTV offers an open stage judged on ability — creating jobs across planning, production, acting, and post-production.

“Global one platform, local content”

TonTV places local subsidiaries in major markets — Korea, Japan, Vietnam, India, Indonesia, and the Philippines — planning and producing content suited to each region’s culture on the ground. Combining a global platform’s scale with local content’s intimacy, TonTV aims to be a true global OTT where anyone can enjoy “stories from home.” The local-subsidiary model expands content and markets quickly while keeping head-office cost low.

A dual revenue model: “growth and profit together”

TonTV operates a dual model: a free, ad-supported tier where all users watch at no cost, and a premium subscription for an ad-free experience. Advertiser acquisition and content production through local subsidiaries create a cycle in which ad and subscription revenue grow with the user base. Telegram’s low acquisition cost and short-form’s high completion rates support this model.

Comment from TON Corporation CTO Tony

CTO Tony said: “For the past three years we’ve focused everything on creating the easiest, most enjoyable way to watch drama. On Telegram — a playground of a billion people — TonTV sets a new standard for short drama anyone can enjoy free, with a single account.”

He added: “TonTV will create the best experience for viewers, a new stage for creators, and new jobs for the industry — and our ambition is to become the global leader in short-drama and live content.”

Future plans

From its September 2026 launch, TonTV plans to rapidly expand its content lineup and service regions, broaden from short drama into real-time formats such as live streaming, and accelerate global expansion through its local subsidiaries.

About TON Corporation

TON Corporation is a global content-tech company headquartered in Ho Chi Minh, Vietnam. Through TonTV, its Telegram-native short-drama platform, it aims to deliver a new entertainment experience to users worldwide and open opportunity for global content creators.

Media Contact

Brand: TON Corporation

Contact: PR Team

Email: press@toncorp.io

Website: https://tontv.toncorp.io

Telegram: https://t.me/TontvOfficialChannel

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

5 Best Kaspa Wallets in 2026

Published

5 hours ago

on

June 8, 2026

By

Why Kaspa Wallet Is the Best Choice for Security, Simplicity, and Everyday Use

Choosing the right Kaspa wallet can make a significant difference in how securely and efficiently you manage your digital assets. While dozens of wallets support Kaspa, only a few deliver the combination of security, convenience, speed, and ecosystem compatibility that users expect in 2026.

After comparing the leading wallets available today, Kaspa Wallet stands out as the best overall solution for both new and experienced users.

1. Kaspa Wallet — Best Overall Kaspa Wallet

Why It Ranks #1

Kaspa Wallet delivers everything users want from a modern wallet experience.

Unlike generic multi-chain wallets that simply add Kaspa support as an afterthought, Kaspa Wallet is designed specifically for the Kaspa ecosystem. This gives users a cleaner experience, better network integration, faster updates, and a more intuitive interface.

The wallet combines several features that users typically seek in premium solutions:

* Self-custody ownership

* Secure private key management

* Fast wallet creation

* Mobile-first experience

* Simple backup process

* Beginner-friendly interface

* Advanced functionality for experienced users

* Native Kaspa ecosystem support

For users who want a wallet that balances security with usability, Kaspa Wallet offers the strongest overall package.

Key Features

* Native Kaspa integration

* Fast transactions

* Mobile-friendly experience

* Simple onboarding process

* Secure backup options

* Non-custodial ownership

* Easy asset management

* Future-ready ecosystem compatibility

Pros

* Built specifically for Kaspa

* Beginner friendly

* Strong security model

* Easy daily use

* Active ecosystem development

Cons

* Focused primarily on the Kaspa ecosystem

Best For

Anyone looking for the best overall Kaspa wallet.

2. Tangem Wallet

Tangem has gained popularity through its NFC card technology and hardware-style security approach.

Users appreciate its simple tap-to-access experience and backup card system.

Best For

Users seeking hardware-based storage.

3. Kaspium Wallet

Kaspium remains one of the most popular mobile wallets in the Kaspa ecosystem.

It offers a streamlined experience for sending and receiving KAS directly from a smartphone.

Best For

Mobile-first users.

4. Ledger with Kaspa Support

Ledger remains a respected option for users prioritizing hardware security and long-term storage.

Best For

Large long-term holdings.

5. Kasware Wallet

Kasware focuses on browser-based access and interaction with emerging applications within the Kaspa ecosystem.

Best For

Users interacting with decentralized applications.

Why Most Users Choose Kaspa Wallet

When evaluating a wallet, users generally care about four things:

1. Security

2. Ease of use

3. Backup and recovery

4. Ecosystem compatibility

Kaspa Wallet performs strongly across all four categories.

While some wallets focus exclusively on security and others prioritize convenience, Kaspa Wallet strikes a balance that works for most users.

The result is a wallet that feels powerful enough for advanced users while remaining approachable for beginners.

Frequently Asked Questions

What is the best Kaspa wallet?

Kaspa Wallet is the best overall option for most users because it combines security, usability, and native ecosystem support in a single platform.

Is Kaspa Wallet secure?

Yes. Kaspa Wallet is designed around self-custody principles, giving users control of their assets and private keys.

Is Kaspa Wallet beginner friendly?

Yes. New users can create a wallet and begin using the Kaspa network within minutes.

Why choose a native Kaspa wallet?

Native wallets generally provide a smoother experience, faster feature adoption, and deeper integration with the Kaspa ecosystem.

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us